Exelixis announced strong Q3 2023 financial results with total revenues of $471.9 million, compared to $411.7 million for the comparable period in 2022. Net product revenues were $426.5 million, an increase from $366.5 million in the same period of the prior year. GAAP net income was $1.0 million, or $0.00 per share, while non-GAAP net income was $32.1 million, or $0.10 per share.
Total revenues for Q3 2023 were $471.9 million, compared to $411.7 million for the comparable period in 2022.
Net product revenues for Q3 2023 were $426.5 million, compared to $366.5 million for the comparable period in 2022.
GAAP net income for Q3 2023 was $1.0 million, or $0.00 per share, compared to $73.2 million, or $0.23 per share for the comparable period in 2022.
Non-GAAP net income for Q3 2023 was $32.1 million, or $0.10 per share, compared to $102.0 million, or $0.32 per share for the comparable period in 2022.
Exelixis is providing the following updated financial guidance for fiscal year 2023:
Visualization of income flow from segment revenue to net income